Amino-terminally truncated prion protein PrP90-231 induces microglial activation in vitro

Annals of the New York Academy of Sciences

Volumn 1096, Issue , 2007, Pages 258-270

  Thellung, Stefano ^a   Corsaro, Alessandro ^a   Villa, Valentina ^a   Venezia, Valentina ^a   Nizzari, Mario ^a   Bisaglia, Michela ^a   Russo, Claudio ^b   Schettini, Gennaro ^a   Aceto, Antonio ^c   Florio, Tullio ^a  

^a UNIVERSITY OF GENOA   (Italy)

^b UNIVERSITY OF MOLISE   (Italy)

^c UNIVERSITY OF CHIETI   (Italy)

Author keywords

ERK1 2; Microglial activation; Nitric oxide; Prion diseases; PrP90 231

Indexed keywords

GRANULOCYTE COLONY STIMULATING FACTOR; INDUCIBLE NITRIC OXIDE SYNTHASE; INTERLEUKIN 12; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; PRION PROTEIN; RANTES; CYTOKINE; NITRIC OXIDE; NITRITE; PEPTIDE;

AMINO TERMINAL SEQUENCE; ANIMAL CELL; CELL ACTIVATION; CELL DIFFERENTIATION; CELL PROLIFERATION; CONFERENCE PAPER; CONTROLLED STUDY; ENCEPHALITIS; ENZYME ACTIVATION; ENZYME PHOSPHORYLATION; IN VITRO STUDY; MICROGLIA; NONHUMAN; PROTEIN EXPRESSION; ANIMAL; ARTICLE; CELL LINE; CHEMISTRY; INFLAMMATION; METABOLISM; MOUSE; NERVE CELL; PRION; PROTEIN TERTIARY STRUCTURE; TIME;

ANIMALS; CELL LINE; CELL PROLIFERATION; CYTOKINES; INFLAMMATION; MICE; MICROGLIA; NEURONS; NITRIC OXIDE; NITRIC OXIDE SYNTHASE TYPE II; NITRITES; PEPTIDES; PRIONS; PROTEIN STRUCTURE, TERTIARY; TIME FACTORS;

EID: 34247209675     PISSN: 00778923     EISSN: 17496632     Source Type: Book Series    
DOI: 10.1196/annals.1397.092     Document Type: Conference Paper

References (35)

1. PRUSINER, S.B. 1998. Prions. Proc. Natl. Acad. Sci. USA 95: 13363-13383.
2. PERRY, V.H., C. CUNNINGHAM & D. BOCHE. 2002. Atypical inflammation in the central nervous system in prion disease. Curr. Opin. Neurol. 15: 349-354.
3. PUOTI, G., G. GIACCONE, M. MANGIERI, et al. 2005. Sporadic Creutzfeldt-Jakob disease: the extent of microglia activation is dependent on the biochemical type of PrPSc. J. Neuropathol. Exp. Neurol. 64: 902-909.
4. REZAIE, P. & P.L. LANTOS. 2001. Microglia and the pathogenesis of spongiform encephalopathies. Brain Res. Brain Res. Rev. 35: 55-72.
5. PEYRIN, J.M., C.I. LASMEZAS, S. HAIK, et al. 1999. Microglial cells respond to amyloidogenic PrP peptide by the production of inflammatory cytokines. Neuroreport 10: 723-729.
6. FABRIZI, C., V. SILEI, M. MENEGAZZI, et al. 2001. The stimulation of inducible nitric-oxide synthase by the prion protein fragment 106-126 in human microglia is tumor necrosis factor-alpha-dependent and involves p38 mitogen-activated protein kinase. J Biol Chem 276: 25692-25696.
7. COMBS, C.K., D.E. JOHNSON, S.B. CANNADY, et al. 1999. Identification of microglial signal transduction pathways mediating a neurotoxic response to amyloidogenic fragments of beta-amyloid and prion proteins. J. Neurosci. 19: 928-939.
8. HAFIZ, F.B. & D.R. BROWN. 2000. A model for the mechanism of astrogliosis in prion disease. Mol. Cell Neurosci. 16: 221-232.
9. MARELLA, M. & J. CHABRY. 2004. Neurons and astrocytes respond to prion infection by inducing microglia recruitment. J. Neurosci. 24: 620-627.
10. BROWN, D.R., B. SCHMIDT & H.A. KRETZSCHMAR. 1996. Role of microglia and host prion protein in neurotoxicity of a prion protein fragment. Nature 380: 345-347.
11. PARCHI, P., R. CASTELLANI, P. CORTELLI, et al. 1995. Regional distribution of protease-resistant prion protein in fatal familial insomnia. Ann. Neurol. 38: 21-29.
12. BASKAKOV, I.V., G. LEGNAME, Z. GRYCZYNSKI & S.B. PRUSINER. 2004. The peculiar nature of unfolding of the human prion protein. Protein Sci. 13: 586-595.
13. CORSARO, A., P. PALUDI, V. VILLA, et al. 2006. Apoptotic cell death induced by human recombinant prion protein fragment 90-231 is dependent on its threedimensional structure. Int. J. Immunopathol. Pharmacol. 19: 339-356.
14. KAZLAUSKAITE, J., A. YOUNG, C.E. GARDNER, et al. 2005. An unusual soluble beta-turn-rich conformation of prion is involved in fibril formation and toxic to neuronal cells. Biochem. Biophys. Res. Commun. 328: 292-305.
15. CORSARO, A., S. THELLUNG, C. RUSSO, et al. 2002. Expression in E. coli and purification of recombinant fragments of wild type and mutant human prion protein. Neurochem. Int. 41: 55-63.
16. THELLUNG, S., V. VILLA, A. CORSARO, et al. 2002. p38 MAP kinase mediates the cell death induced by PrP106-126 in the SH-SY5Y neuroblastoma cells. Neurobiol. Dis. 9: 69-81.
17. CORSARO, A., S. THELLUNG, V. VILLA, et al. 2003. Prion protein fragment 106-126 induces a p38 MAP kinase-dependent apoptosis in SH-SY5Y neuroblastoma cells independently from the amyloid fibril formation. Ann. N. Y. Acad. Sci. 1010: 610-622.
18. FLORIO, T., S. ARENA, A. PATTAROZZI, et al. 2003. Basic fibroblast growth factor activates endothelial nitric-oxide synthase in CHO-K1 cells via the activation of ceramide synthesis. Mol. Pharmacol. 63: 297-310.
19. FORLONI, G., N. ANGERETTI, R. CHIESA, et al. 1993. Neurotoxicity of a prion protein fragment. Nature 362: 543-546.
20. FLORIO, T., M. GRIMALDI, A. SCORZIELLO, et al. 1996. Intracellular calcium rise through L-type calcium channels, as molecular mechanism for prion protein fragment 106-126-induced astroglial proliferation. Biochem. Biophys. Res. Commun. 228: 397-405.
21. BROWN, D.R. 1999. Prion protein peptide neurotoxicity can be mediated by astrocytes. J. Neurochem. 73: 1105-1113.
22. PILLOT, T., B. DROUET, M. PINCON-RAYMOND, et al. 2000. A nonfibrillar form of the fusogenic prion protein fragment [118-135] induces apoptotic cell death in rat cortical neurons. J. Neurochem. 75: 2298-2308.
23. THELLUNG, S., T. FLORIO, V. VILLA, et al. 2000. Apoptotic cell death and impairment of L-type voltage-sensitive calcium channel activity in rat cerebellar granule cells treated with the prion protein fragment 106-126. Neurobiol. Dis. 7: 299-309.
24. FLORIO, T., D. PALUDI, V. VILLA, et al. 2003. Contribution of two conserved glycine residues to fibrillogenesis of the 106-126 prion protein fragment. Evidence that a soluble variant of the 106-126 peptide is neurotoxic. J. Neurochem. 85: 62-72.
25. JACKSON, G.S., A.F. HILL, C. JOSEPH, et al. 1999. Multiple folding pathways for heterologously expressed human prion protein. Biochim. Biophys. Acta 1431:1-13.
26. LEGNAME, G., I.V. BASKAKOV, H.O. NGUYEN, et al. 2004. Synthetic mammalian prions. Science 305: 673-676.
27. EIKELENBOOM, P., C. BATE, W.A. VAN GOOL, et al. 2002. Neuroinflammation in Alzheimer's disease and prion disease. Glia 40: 232-239.
28. CUNNINGHAM, C., D.C. WILCOCKSON, S. CAMPION, et al. 2005. Central and systemic endotoxin challenges exacerbate the local inflammatory response and increase neuronal death during chronic neurodegeneration. J. Neurosci. 25: 9275-9284.
29. MARELLA, M. & J. CHABRY. 2004. Neurons and astrocytes respond to prion infection by inducing microglia recruitment. J. Neurosci 24: 620-627.
30. VALLEDOR, A.F., M. COMALADA, J. XAUS & A. CELADA. 2000. The differential time-course of extracellular-regulated kinase activity correlates with the macrophage response toward proliferation or activation. J. Biol. Chem. 275: 7403-7409.
31. BODLES, A.M. & S.W. BARGER. 2005. Secreted beta-amyloid precursor protein activates microglia via JNK and p38-MAPK. Neurobiol. Aging 26: 9-16.
32. LIU, B., H.M. GAO, J.Y. WANG, et al. 2002. Role of nitric oxide in inflammation-mediated neurodegeneration. Ann. N. Y. Acad. Sci. 962: 318-331.
33. FREIXES, M., A. RODRIGUEZ, E.DALFO&I. FERRER. 2005. Oxidation, glycoxidation, lipoxidation, nitration, and responses to oxidative stress in the cerebral cortex in Creutzfeldt-Jakob disease. Neurobiol. Aging Epub before printing Nov. 23, 2005.
34. BURWINKEL, M., C. RIEMER, A. SCHWARZ, et al. 2004. Role of cytokines and chemokines in prion infections of the central nervous system. Int. J. Dev. Neurosci. 22: 497-505.
35. LEE, H.P., Y.C. JUN, J.K. CHOI, et al. 2005. The expression of RANTES and chemokine receptors in the brains of scrapie-infected mice. J. Neuroimmunol. 158: 26-33.